China Health Industries Holdings Inc CHHEの前四半期の収益はどうでしたか?
China Health Industries Holdings Incの収益見積もりはいくらですか?
China Health Industries Holdings Incの収益品質スコアはどれくらいですか?
China Health Industries Holdings Incはいつ収益を報告しますか?
China Health Industries Holdings Incの予想収益はいくらですか?
China Health Industries Holdings Incは収益予想を上回りましたか?
主要データ
前終値
$0.0001
始値
$0
当日レンジ
$0 - $0
52週レンジ
$0 - $0.2225
取引高
1.0K
平均取引高
0
1株当たり利益(TTM)
-0.02
配当利回り
--
時価総額
$6.5K
CHHEとは何ですか?
China Health Industries Holdings, Inc. engages in the production, marketing, and distribution of medicines, health products, health devices, and cosmetics. The company is headquartered in Harbin, Heilongjiang and currently employs 32 full-time employees. The company went IPO on 2004-12-01. The firm's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The firm's products include soft capsule, hard capsule, tablet, granule, oral liquid forms which address the needs of some key sectors in China, including the feminine, geriatric, and children’s markets.